Tuesday, January 13, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Almonty’s Strategic Pivot: From Defense to Fusion Energy

Felix Baarz by Felix Baarz
January 13, 2026
in Commodities, Defense & Aerospace, Energy & Oil, Industrial, Nasdaq
0
Almonty Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Investor attention is turning toward Almonty Industries Inc. as the tungsten producer becomes linked to two powerful market narratives: sustained defense sector demand and its emerging potential role in fusion energy technology. The company’s shares are currently trading near CAD 12.64 on the Toronto Stock Exchange and approximately USD 9.00 on the Nasdaq. This renewed interest follows the official transition of its flagship Sangdong project in South Korea to commercial production in December 2025.

Operational Milestones and Financial Strengthening

Beyond the thematic narratives, Almonty’s valuation is supported by concrete operational progress and a fortified balance sheet.

  • Commencement of Commercial Mining: On December 16, 2025, Almonty initiated commercial mining operations at the Sangdong mine. The delivery of first ores to the run-of-mine stockpile represented the final major step in mitigating project execution risks, with production now being ramped up systematically.
  • Substantial Capital Raise Finalized: In December 2025, the company closed a significantly oversubscribed financing round. Gross proceeds totaled approximately USD 129.4 million, exceeding the initially targeted USD 112.5 million. The placement price was set at USD 6.25 per share, providing funds for the final commissioning phase at Sangdong and near-term balance sheet relief.
  • Executive Team Expansion: Effective January 6, 2026, Guillaume Wiesenbach de Lamaziere joined the leadership team as Chief Development Officer. This newly created position signals a strategic shift from pure project execution to broader corporate development and international market expansion.

A Dual-Themed Investment Case

Traditionally viewed as a security-of-supply provider for ammunition and armor, Almonty is now gaining recognition for tungsten’s strategic importance in next-generation energy. Recent analysis highlights the metal’s application in fusion research, where tungsten wall components in projects like Tokamak-WEST have contributed to achieving high-temperature, stable plasma states. These technical advances are directing focus toward non-Chinese sources of tungsten, with Almonty being explicitly cited in recent market commentary as a key Western supplier.

Some observers are beginning to categorize the company’s geopolitical significance alongside established defense contractors like Rheinmetall. This broader demand profile has supported a notable share price appreciation from its mid-2025 levels.

Positioning as a Western Supply Chain Anchor

Amid political efforts in North America and Europe to reduce critical mineral dependencies on China—which controls over 80% of global tungsten supply—Almonty’s strategic weight is increasing. The company is positioning itself as a reliable Western alternative, a move further bolstered by its Nasdaq listing in July 2025, which improved access to U.S. institutional and retail investors.

Should investors sell immediately? Or is it worth buying Almonty?

This evolving story is reflected in the equity’s trajectory:
* July 2025 financing at USD 4.50 per share
* December 2025 capital raise at USD 6.25 per share
* Current trading level around USD 9.00 per share

The rising placement prices and market absorption of new supply indicate growing investor confidence in both the Sangdong ramp-up and the firm’s long-term strategic role.

Forward Outlook and Key Levels to Watch

Upcoming quarterly reports will be crucial for demonstrating the speed and stability of Sangdong’s production increase. Concurrently, the discussion around fusion energy provides a potential long-term growth driver alongside the established defense demand.

From a technical perspective, the zone around CAD 12.75 on the TSX is seen as a significant resistance level. A sustained breakout above this point would be interpreted by many market participants as confirmation of the prevailing upward trend. Additionally, the expiration of lock-up agreements on January 8, 2026, passed without notable selling pressure—a positive signal that early investors are awaiting the transition to full-scale production.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from January 13 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 13.

Almonty: Buy or sell? Read more here...

Tags: Almonty
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

CureVac Stock
Mergers & Acquisitions

CureVac’s Stock Journey Concludes Following BioNTech Acquisition

January 13, 2026
PayPal Stock
Analysis

Analyst Downgrade Overshadows PayPal’s Strategic Moves

January 13, 2026
Alphabet Stock
AI & Quantum Computing

Alphabet Reaches Historic Valuation Milestone on Dual Strategic Wins

January 13, 2026

Recommended

Blackbaud Stock

Blackbaud Emerges as Quiet Performer in Non-Profit Software Sector

5 months ago
Warner Bros. Discovery (A) Stock

Analysts Sound Caution on Warner Bros. Discovery Shares Despite Strong Performance

4 months ago
Summit Hotel Properties Stock

Summit Hotel Properties Maintains Dividend Amid Challenging Quarter

5 months ago
EOG stock news

SG Americas Securities LLC Strengthens Portfolio with Strategic Investment in Coastal Financial Co.

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

A Deep Dive into the iShares MSCI World ETF’s Performance and Strategy

Pfizer’s Strategic Shift Weighs on Investor Sentiment

Analyst Downgrade Overshadows PayPal’s Strategic Moves

Ethereum’s Quiet Consolidation Masks a Strengthening Foundation

Fiserv Embarks on Strategic AI Push Amid Leadership Reshuffle

Alphabet Reaches Historic Valuation Milestone on Dual Strategic Wins

Trending

Almonty Stock
Commodities

Almonty’s Strategic Pivot: From Defense to Fusion Energy

by Felix Baarz
January 13, 2026
0

Investor attention is turning toward Almonty Industries Inc. as the tungsten producer becomes linked to two powerful...

Novo Nordisk Stock

Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach

January 13, 2026
CureVac Stock

CureVac’s Stock Journey Concludes Following BioNTech Acquisition

January 13, 2026
MSCI World ETF Stock

A Deep Dive into the iShares MSCI World ETF’s Performance and Strategy

January 13, 2026
Pfizer Stock

Pfizer’s Strategic Shift Weighs on Investor Sentiment

January 13, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Almonty’s Strategic Pivot: From Defense to Fusion Energy
  • Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach
  • CureVac’s Stock Journey Concludes Following BioNTech Acquisition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com